Prostate Oligometastatic Cancer Management Driven by Disease Biology et/or Immunoactivity (PROMETEO)
NCT06060652
·
clinicaltrials.gov ↗
UNKNOWN
Status
104
Enrollment
OTHER
Sponsor class
Conditions
Oligometastatic Prostate Cancer
Sponsor
Centro di Riferimento Oncologico - Aviano